لا يتم عرض هذه النتيجة على الضيوف.
تسجيل الدخول للوصول الكامل.

المؤلفون: Sandrine Faivre, Patricia Niccoli, Aaron I. Vinik, Peter Metrakos, C. Lombard-Bohas, D. Smith, Y.-J. Bang, K.J. Ishak, Pascal Hammel, Shem Patyna, Jean-Luc Raoul, E. Raymond, Jin-Shyr Chen, E. Van Cutsem, Ivan Borbath, Daniel Castellano, D. Lu, Juan W. Valle, J.F. Seitz, Philippe Ruszniewski, Sang Hyub Lee

المصدر: Faivre, S, Niccoli, P, Castellano, D, Valle, J W, Hammel, P, Raoul, J-L, Vinik, A, Van Cutsem, E, Bang, Y-J, Lee, S-H, Borbath, I, Lombard-Bohas, C, Metrakos, P, Smith, D, Chen, J-S, Ruszniewski, P, Seitz, J-F, Patyna, S, Lu, D R, Ishak, K J & Raymond, E 2017, ' Sunitinib in Pancreatic Neuroendocrine Tumors : Updated Progression-Free Survival and Final Overall Survival From a Phase III Randomized Study ', Annals of Oncology . https://doi.org/10.1093/annonc/mdw561

مصطلحات موضوعية: 0301 basic medicine, Oncology, medicine.medical_specialty, Indoles, Urology, Antineoplastic Agents, Kaplan-Meier Estimate, Neuroendocrine tumors, Placebo, Disease-Free Survival, law.invention, 03 medical and health sciences, 0302 clinical medicine, Double-Blind Method, Randomized controlled trial, law, Internal medicine, Statistical significance, Sunitinib, medicine, Humans, Pyrroles, Progression-free survival, Proportional Hazards Models, Manchester Cancer Research Centre, Proportional hazards model, business.industry, ResearchInstitutes_Networks_Beacons/mcrc, Hematology, medicine.disease, Confidence interval, Pancreatic Neoplasms, Survival Rate, Neuroendocrine Tumors, Cross-Sectional Studies, 030104 developmental biology, 030220 oncology & carcinogenesis, business, medicine.drug

URL الوصول: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::aa1c75abe5aba1d51efbc55f02d519c7
https://doi.org/10.1093/annonc/mdw561

المؤلفون: G. Des Guetz, O. Bouche, Trevor Stanbury, S. Charpentier, F. Ghiringhelli, E. Francois, Marc G. Denis, Antoine Adenis, Pascal Artru, J. Bennouna, Sandrine Hiret, Christophe Borg, Gael Deplanque, T. Conroy, J.F. Seitz, Aurélie Bertaut

المساهمون: Service d'hépato-gastro-entérologie, cancérologie digestive et assistance nutritionnelle [CHU de Nantes], Centre hospitalier universitaire de Nantes (CHU Nantes), Institut de Cancérologie de l'Ouest [Angers/Nantes] (UNICANCER/ICO), UNICANCER, Service d'Oncologie Médicale [CHRU Besançon], Centre Hospitalier Régional Universitaire de Besançon (CHRU Besançon)-Université de Franche-Comté (UFC), Université Bourgogne Franche-Comté [COMUE] (UBFC)-Université Bourgogne Franche-Comté [COMUE] (UBFC), Service Biostatistiques et Informatique Médicale (CHU de Dijon) (DIM), Centre Hospitalier Universitaire de Dijon - Hôpital François Mitterrand (CHU Dijon), Centre Hospitalier Universitaire de Reims (CHU Reims), Service d'oncologie médicale (Centre Antoine Lacassagne, Nice), Centre de Lutte contre le Cancer Antoine Lacassagne [Nice] (UNICANCER/CAL), UNICANCER-Université Côte d'Azur (UCA)-UNICANCER-Université Côte d'Azur (UCA), Département d’Oncologie Médicale [Vandoeuvre Les Nancy], Institut de Cancérologie de Lorraine - Alexis Vautrin [Nancy] (UNICANCER/ICL), UNICANCER-UNICANCER, Département d'oncologie médicale [Centre Georges-François Leclerc], Centre Régional de Lutte contre le cancer Georges-François Leclerc [Dijon] (UNICANCER/CRLCC-CGFL), Service d'Oncologie médicale [CHU Limoges], CHU Limoges, Service d'hépatologie et de gastroentérologie [Hôpital Saint-Joseph - Marseille], Aix Marseille Université (AMU)-Hôpital Saint-Joseph [Marseille], Clinique Jean-Mermoz, Hôpital privé Jean Mermoz, R&D UNICANCER, Fédération Nationale des Centres de Lutte Contre le Cancer (FNCLCL/UNICANCER), AGROCAMPUS OUEST, Institut national d'enseignement supérieur pour l'agriculture, l'alimentation et l'environnement (Institut Agro), Service de génétique médicale - Unité de génétique clinique [Nantes], Université de Nantes (UN)-Centre hospitalier universitaire de Nantes (CHU Nantes), Centre Régional de Lutte contre le Cancer Oscar Lambret [Lille] (UNICANCER/Lille), Université Lille Nord de France (COMUE)-UNICANCER, Université de Lille-UNICANCER

المصدر: Annals of oncology (ISSN : 0923-7534)
ESMO 2017 Congress
ESMO 2017 Congress, Sep 2017, Madrid, Spain. pp.477O, ⟨10.1093/annonc/mdx393.004⟩

مصطلحات موضوعية: 0301 basic medicine, Oncology, medicine.medical_specialty, Bevacizumab, Colorectal cancer, medicine.medical_treatment, Phases of clinical research, [SDV.CAN]Life Sciences [q-bio]/Cancer, bevacizumab, medicine.disease_cause, phase 2 clinical trials, kras2 gene, chemotherapy regimen, 03 medical and health sciences, 0302 clinical medicine, Internal medicine, cetuximab, medicine, Chemotherapy, Cetuximab, business.industry, Wild type, Hematology, medicine.disease, Chemotherapy regimen, 3. Good health, k-ras oncogene, 030104 developmental biology, 030220 oncology & carcinogenesis, colorectal cancer metastatic, KRAS, business, medicine.drug

URL الوصول: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::9d2af92c3c00dc6ad9232e825263ffb8
https://hal.archives-ouvertes.fr/hal-01626269

المؤلفون: Pierre Laurent-Puig, Sylvain Poujol, Françoise Desseigne, S. Thezenas, Thibault Mazard, Evelyne Crapez, Emmanuelle Samalin, E. Francois, Antoine Adenis, T. Conroy, J.F. Seitz, Julien Taieb, M.P. Galais, Jaafar Bennouna, F. Boissière, Marc Ychou, Eric Assenat, O. Bouche, Frédéric Bibeau

المساهمون: CRLCC Val d'Aurelle - Paul Lamarque, Hôpital universitaire Robert Debré [Reims], Centre de Lutte contre le Cancer Antoine Lacassagne [Nice] (UNICANCER/CAL), UNICANCER-Université Côte d'Azur (UCA), Centre Régional de Lutte contre le Cancer Oscar Lambret [Lille] (UNICANCER/Lille), Université de Lille-UNICANCER, Institut de Cancérologie de l'Ouest [Angers/Nantes] (UNICANCER/ICO), UNICANCER, CIC - HEGP (CIC 1418), Assistance publique - Hôpitaux de Paris (AP-HP) (AP-HP)-Hôpital Européen Georges Pompidou [APHP] (HEGP), Assistance publique - Hôpitaux de Paris (AP-HP) (AP-HP)-Hôpitaux Universitaires Paris Ouest - Hôpitaux Universitaires Île de France Ouest (HUPO)-Hôpitaux Universitaires Paris Ouest - Hôpitaux Universitaires Île de France Ouest (HUPO)-Université Paris Descartes - Paris 5 (UPD5)-Institut National de la Santé et de la Recherche Médicale (INSERM), Centre Léon Bérard [Lyon], Hôpital de la Timone [CHU - APHM] (TIMONE), Institut de Cancérologie de Lorraine - Alexis Vautrin [Nancy] (UNICANCER/ICL), Centre Régional de Lutte contre le Cancer François Baclesse [Caen] (UNICANCER/CRLC), Normandie Université (NU)-UNICANCER-Tumorothèque de Caen Basse-Normandie (TCBN), Institut de Génétique Moléculaire de Montpellier (IGMM), Université de Montpellier (UM)-Centre National de la Recherche Scientifique (CNRS), Institut de recherche en cancérologie de Montpellier (IRCM - U896 Inserm - UM1), Université Montpellier 1 (UM1)-CRLCC Val d'Aurelle - Paul Lamarque-Institut National de la Santé et de la Recherche Médicale (INSERM)-Université de Montpellier (UM), CRLC Val d'Aurelle-Paul Lamarque, Hôpital Européen Georges Pompidou [APHP] (HEGP), Assistance publique - Hôpitaux de Paris (AP-HP) (AP-HP)-Hôpitaux Universitaires Paris Ouest - Hôpitaux Universitaires Île de France Ouest (HUPO), Université Lille Nord de France (COMUE)-UNICANCER, UNICANCER-Tumorothèque de Caen Basse-Normandie (TCBN)-Normandie Université (NU), Centre National de la Recherche Scientifique (CNRS)-Université de Montpellier (UM), CRLCC Val d'Aurelle - Paul Lamarque-Université de Montpellier (UM)-Institut National de la Santé et de la Recherche Médicale (INSERM)-Université Montpellier 1 (UM1), Institut de Recherche en Cancérologie de Montpellier (IRCM - U1194 Inserm - UM), CRLCC Val d'Aurelle - Paul Lamarque-Institut National de la Santé et de la Recherche Médicale (INSERM)-Université de Montpellier (UM), Centre Antoine Lacassagne, CRLCC Antoine Lacassagne, CRLCC Oscar Lambret, Institut de Cancérologie de l'Ouest, Assistance publique - Hôpitaux de Paris (AP-HP) (APHP)-Hôpital Européen Georges Pompidou [APHP] (HEGP), Hôpitaux Universitaires Paris Ouest - Hôpitaux Universitaires Île de France Ouest (HUPO)-Assistance publique - Hôpitaux de Paris (AP-HP) (APHP)-Hôpitaux Universitaires Paris Ouest - Hôpitaux Universitaires Île de France Ouest (HUPO)-Université Paris Descartes - Paris 5 (UPD5)-Institut National de la Santé et de la Recherche Médicale (INSERM), Institut de Cancérologie de Lorraine - Alexis Vautrin (ICL), Centre Régional de Lutte contre le Cancer François Baclesse (CRLC François Baclesse ), Normandie Université (NU)-Tumorothèque de Caen Basse-Normandie (TCBN), Hôpitaux Universitaires Paris Ouest - Hôpitaux Universitaires Île de France Ouest (HUPO)-Assistance publique - Hôpitaux de Paris (AP-HP) (APHP)

المصدر: British Journal of Cancer
Breast Cancer Research and Treatment
Breast Cancer Research and Treatment, 2014, 110, pp.1148--54. ⟨10.1038/bjc.2013.813⟩
Breast Cancer Research and Treatment, Springer Verlag, 2014, 110, pp.1148--54. ⟨10.1038/bjc.2013.813⟩

مصطلحات موضوعية: Male, Cancer Research, Colorectal cancer, medicine.medical_treatment, Camptothecin/administration & dosage/analogs & derivatives, Gastroenterology, tyrosine kinase inhibitor, Antineoplastic Combined Chemotherapy Protocols, Clinical endpoint, 80 and over, clinic, Aged, 80 and over, education.field_of_study, metastatic colorectal cancer, ras Proteins/*genetics, Mutation, Middle Aged, Sorafenib, 3. Good health, Oncology, Disease Progression, Female, Colorectal Neoplasms, medicine.drug, Adult, Niacinamide, medicine.medical_specialty, Niacinamide/administration & dosage/analogs & derivatives, Population, Colorectal Neoplasms/*drug therapy/genetics, [SDV.CAN]Life Sciences [q-bio]/Cancer, Neutropenia, Irinotecan, Disease-Free Survival, Proto-Oncogene Proteins p21(ras), Internal medicine, Proto-Oncogene Proteins, medicine, Humans, Antineoplastic Combined Chemotherapy Protocols/*therapeutic use, education, neoplasms, Aged, Chemotherapy, business.industry, Phenylurea Compounds, medicine.disease, digestive system diseases, Surgery, KRAS gene mutation, Regimen, Phenylurea Compounds/administration & dosage, Clinical Study, ras Proteins, Proto-Oncogene Proteins/*genetics, Camptothecin, business

URL الوصول: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::0de27d5b42bd45149c4970a8cb5a2512
http://europepmc.org/articles/PMC3950852

المؤلفون: E. Francois, T. Andre, Timothy J. Price, Julien Edeline, Fabienne Portales, Julien Taieb, E. Van Cutsem, Alfredo Falcone, Nadjat Mounedji, S. Moreno Vera, J.F. Seitz, Martin Becquart, J.M. Phelip

المصدر: Annals of Oncology. 29:v104-v105

مصطلحات موضوعية: Oncology, medicine.medical_specialty, business.industry, Colorectal cancer, 02 engineering and technology, Hematology, 021001 nanoscience & nanotechnology, medicine.disease, 03 medical and health sciences, 0302 clinical medicine, 030220 oncology & carcinogenesis, Internal medicine, Medicine, Open label, 0210 nano-technology, business, Previously treated

URL الوصول: https://explore.openaire.eu/search/publication?articleId=doi_________::4f629115d2ab82269ef8b3f4d5a8aac5
https://doi.org/10.1093/annonc/mdy149.012

المؤلفون: A. Abakar Mahamat, Faiza Khemissa, Thibault Mazard, J.F. Seitz, Eric Francois, Patrick Bachmann, Xavier Hébuterne, L. Mineur, Isabelle Besnard, Stéphane M. Schneider, Pierre Senesse

المصدر: Nutrition Clinique et Métabolisme. 32:231

مصطلحات موضوعية: Nutrition and Dietetics, Endocrinology, Diabetes and Metabolism, Internal Medicine

URL الوصول: https://explore.openaire.eu/search/publication?articleId=doi_________::b8b002b4d1c7aec9c46a962b624633f2
https://doi.org/10.1016/j.nupar.2018.09.006

المؤلفون: A. de Reyniès, Yuna Blum, Gérard Milano, Julien Taieb, Côme Lepage, Daniela Aust, Alex Duval, Valérie Boige, Camilla Pilati, R. Salazar, K. Le Malicot, Mira Ayadi, J.F. Seitz, Pierre Laurent-Puig, Laetitia Marisa, J.F. Emile, Janick Selves, Dominique Guenot, Ralyath Balogoun

المصدر: Annals of Oncology. 29:viii18

مصطلحات موضوعية: 0301 basic medicine, Colorectal cancer, business.industry, Hematology, medicine.disease, Molecular analysis, 03 medical and health sciences, 030104 developmental biology, 0302 clinical medicine, Oncology, 030220 oncology & carcinogenesis, medicine, Cancer research, business

URL الوصول: https://explore.openaire.eu/search/publication?articleId=doi_________::e2b23d6d1cc01e7a743a48c0a0ae9844
https://doi.org/10.1093/annonc/mdy269.058

المؤلفون: E. Francois, Isabelle Besnard, A. Abakar Mahamat, E. Assenat, Pierre Senesse, Xavier Hébuterne, L. Mineur, Patrick Bachmann, Stéphane M. Schneider, F. Khemissa Akouz, J.F. Seitz

المصدر: Clinical Nutrition. 37:S14

مصطلحات موضوعية: Oncology, medicine.medical_specialty, Nutrition and Dietetics, business.industry, Colorectal cancer, Internal medicine, Toxicity, medicine, In patient, First line chemotherapy, Critical Care and Intensive Care Medicine, business, medicine.disease

URL الوصول: https://explore.openaire.eu/search/publication?articleId=doi_________::8ea7c2e2b801b63014481748e5e66996
https://doi.org/10.1016/j.clnu.2018.06.1116

المؤلفون: R. Lamy, Patrice Viens, J-L. Raoul, Rémy Largillier, Mohamed Gasmi, J.F. Seitz, Benjamin Esterni, J. R. Delpero, Hervé Perrier, Olivier Turrini, Laurence Moureau-Zabotto, X. Tchiknavorian, M Giovannini, E. Francois, Dominique Genre, A. Goncalves, D. Re, Marine Gilabert, Laetitia Dahan

المصدر: Annals of Oncology. 23:2799-2805

مصطلحات موضوعية: Adult, Male, Niacinamide, Oncology, Sorafenib, Antimetabolites, Antineoplastic, medicine.medical_specialty, Antineoplastic Agents, Placebo, Deoxycytidine, Disease-Free Survival, law.invention, Placebos, Double-Blind Method, Randomized controlled trial, law, Pancreatic cancer, Internal medicine, Antineoplastic Combined Chemotherapy Protocols, Ribonucleotide Reductases, medicine, Clinical endpoint, Humans, Protein Kinase Inhibitors, Aged, Aged, 80 and over, Performance status, business.industry, Phenylurea Compounds, Hematology, Middle Aged, medicine.disease, Gemcitabine, Pancreatic Neoplasms, Clinical trial, Female, business, medicine.drug

URL الوصول: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::2f759a652be19ef663edd6fe132a07cc
https://doi.org/10.1093/annonc/mds135

المؤلفون: C. Louvet, E. Boucher, F. Bonnetain, M. Benabdelghani, J.F. Seitz, Laetitia Fartoux, Roger Faroux, Julien Edeline, Beata Juzyna, J-L. Jouve, Jérôme Watelet, Eric Assenat, David Malka, Aurélie Bertaut, Pascal Hammel, Karine Bouhier-Leporrier, J.M. Phelip, Trevor Stanbury, J-P. Joly, Veronique Guerin-Meyer

المصدر: Annals of Oncology. 28:v617

مصطلحات موضوعية: medicine.medical_specialty, Biliary tract cancer, business.industry, 05 social sciences, Hematology, GemOx, Relapse free survival, Gastroenterology, 03 medical and health sciences, 0302 clinical medicine, Pharmaceutical Adjuvants, Oncology, 030220 oncology & carcinogenesis, Internal medicine, 0502 economics and business, medicine, Overall survival, 050211 marketing, business

URL الوصول: https://explore.openaire.eu/search/publication?articleId=doi_________::a6c1ddceed63246d4a5a0d574604c1f8
https://doi.org/10.1093/annonc/mdx440.021